THAR
Hillstream BioPharma Inc

2,991
Mkt Cap
$23.51M
Volume
303,401.00
52W High
$9.08
52W Low
$0.952
PE Ratio
-0.51
THAR Fundamentals
Price
$3.09
Prev Close
$2.90
Open
$2.93
50D MA
$3.40
Beta
0.85
Avg. Volume
1.06M
EPS (Annual)
-$9.41
P/B
35.51
Rev/Employee
$0.00
Loading...
Loading...
Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or uncontrollable itching in PBC, a rare and orphan liver disease with no known cure. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2

Frequently Asked Questions

What is Market Cap of Tharimmune Inc?
What is the 52-week high for Tharimmune Inc?
What is the 52-week low for Tharimmune Inc?
What is Tharimmune Inc stock price today?
What was Tharimmune Inc stock price yesterday?
What is the PE ratio of Tharimmune Inc?
What is the Price-to-Book ratio of Tharimmune Inc?
What is the 50-day moving average of Tharimmune Inc?
How many employess does Tharimmune Inc has?

Latest THAR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.